Both of the two assays showed that knock-down of CDKN2A could results an enhanced proliferative ability in SW1088 cells (Figure 2J, 2K), which showed the CDKN2A also act as a tumor suppressor in LGG cells. This evidence concerns the gene CDKN2A and neoplasm.